CD19 chimeric antigen receptor (CAR) engineered epstein-barr virus (EBV) specific T cells – an off-the-shelf, allogeneic CAR T-cell immunotherapy platform von Shen, R.R, Pham, C.D, Wu, M, Munson, D.J, Aftab, B.T

Volltext

Immunotherapy: EVALUATION OF NON-GENE EDITED ALLOGENEIC “OFF-THE-SHELF” Vδ1 γδ CAR T CELLS TARGETING CD20 FOR B CELL MALIGNANCIES von Azameera, A., Lamture, G., Au, M., Barca, T., Teague, A., Wong, J., Gundurao, S.R., Doan, A., Herrman, M., Panuganti, S., Bhat, A., Aftab, B.T., Nishimoto, K.

Volltext

Gene expression profiling and TCR diversity of ATA188, a Pre-manufactured, Allogeneic Epstein-Barr Virus-targeted T-cell Immunotherapy for Patients with Multiple Sclerosis von Foubert, P., Srihari, S., Le Textier, L., Shen, R.R., Forozan, F., Smith, C., Khanna, R., Aftab, B.T.

Volltext

Developing adoptive T cell therapy for Polyomavirus-associated diseases using HLA-defined peptide platform von Thomas, G. Ambalathingal, FRancis, R.S., Corvino, D., Srihari, S., Nellar, M., Aftab, B.T., Smith, C., Khanna, R.

Volltext

Comprehensive activation profiling of tabelecleucel, an off-the-shelf, allogeneic EBV-specific T-cell immunotherapy von Ruiz, F., Jehng, T., Spindler, T., Munson, D.J., Karlen, J., Thota, V., Wang, A., Chuan, J., Yedwabnick, M., Dubovksy, J., Aftab, B.T.

Volltext

Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransp... von Prockop, S., Shen, R.R., Guzman-Becerra, N., Sun, Y., Forozan, F., Doubrovina, E., O'Reilly, R.J., Li, X., Hiremath, M., Gamelin, L., Navarro, W., Aftab, B.T.

Volltext

Comprehensive profiling of ATA188, an off-the-shelf, allogeneic epstein-barr virus-specific T-cell immunotherapy for progressive multiple sclerosis von Moreno, M., Srihari, S., Ruiz, F., Ambalathingal Thomas, G., Le Texier, L., Panikkar, A., Raju, J., Rehan, S., Beagley, L., Solomon, M., Smith, C., Dubovsky, J., Khanna, R., Aftab, B.T.

Volltext